All Stories

  1. HERACLIS‐TAF : a multicentre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks

    Article • Alimentary Pharmacology & Therapeutics, June 2022, Wiley

    Dr STYLIANOS KARATAPANIS

  2. Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: Does ethnicity matter?

    Article • Journal of Medical Virology, June 2012, Wiley

    Dr STYLIANOS KARATAPANIS